| Source: |
| Type: |
| CYP2C9, cytochrome P450 enzyme – CYP2C9 is involved in the metabolism of a range of xenobiotics, including several anticancer drugs, which can affect drug efficacy and toxicity. – Although CYP2C9 is not traditionally considered an oncogene or tumor suppressor, its expression and genetic variants can influence patient responses to chemotherapy. |
| 1152- | Api, | Does Oral Apigenin Have Real Potential for a Therapeutic Effect in the Context of Human Gastrointestinal and Other Cancers? |
| - | Analysis, | Nor, | NA |
| 5480- | BM, | Inhibition of Human Cytochrome P450 Enzymes by Bacopa monnieri Standardized Extract and Constituents |
| - | Human, | Nor, | NA |
| 6137- | CHr, | Effects of Chrysin and Its Major Conjugated Metabolites Chrysin-7-Sulfate and Chrysin-7-Glucuronide on Cytochrome P450 Enzymes and on OATP, P-gp, BCRP, and MRP2 Transporters |
| - | in-vitro, | NA, | NA |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:1130 State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid